EJVaios Profile Banner
Eugene Vaios, MD MBA Profile
Eugene Vaios, MD MBA

@EJVaios

Followers
225
Following
1K
Media
14
Statuses
297

Radiation Oncology resident @dukecancer @dukeradonc | MD/MBA '19 @HarvardMed @harvardhbs | AB '14 @Harvard

Durham, NC
Joined April 2017
Don't wanna be here? Send us removal request.
@EJVaios
Eugene Vaios, MD MBA
2 years
Fantastic work @SebastianWinter!
@SebastianWinter
Sebastian F. Winter, MD PhD
2 years
Our latest publication out in Journal of Neurology @SpringerNature explores #AI in #neurology and #brainhealth 🧠 A joy collaborating with diverse experts @pkarschnia @EJVaios @IraHaraldsen @ValeryFeigin @White_Lab_Brown @pswieboda @vivnat & others! ▶️ https://t.co/HROcbyoE0s
0
0
4
@HBSAlumni
HBS Alumni
2 years
@EJVaios @klgendron12 @Aartikochhar & @rqian: As alumni interested in leadership, you may like this post from the #HBR archives in case you missed it,
0
1
4
@PDBrownOnc
PDBrown
2 years
Brief review re: targeting mutant IDH in gliomas by Drs. Reardon & Cahill As noted by authors to go 15 years from discovery to targeted therapy is impressive. https://t.co/xNPESUFdUO
0
6
31
@EJVaios
Eugene Vaios, MD MBA
2 years
Couldn’t agree more!
0
0
1
@MGHNeuroOnc
MGHNeuroOncology
2 years
Neurotoxicity and management of primary and secondary CNS lymphoma after adoptive immunotherapy with CD19-directed CAR T-cells
Tweet card summary image
academic.oup.com
AbstractBackground. Chimeric antigen receptor (CAR) T-cells targeting CD19 have been established as a leading engineered T-cell therapy for B-cell lymphoma
0
4
10
@DukeRadOnc
Duke Radiation Oncology
2 years
We're excited to welcome our exceptional new resident classes! Glad to have you here at Duke #RadOnc 💙 @DukeCancer @DukeMedSchool
0
3
18
@EJVaios
Eugene Vaios, MD MBA
2 years
I’ve served as an interviewer for @Harvard for several years. Achievement so often comes down to the circumstances we’re born into. Affirmative action was imperfect, but it acknowledged this reality and allowed us to discover talents otherwise overlooked. @harvardmed @HarvardHBS
0
0
6
@EJVaios
Eugene Vaios, MD MBA
2 years
Congrats to Dr. Batich, @MKhasraw, and the brain tumor team at @Dukeneurosurg @DukeCancer on this important work!
@NeuroOnc
SNO
2 years
Dendritic cell vaccine trials in gliomas: Untangling the lines https://t.co/FLzt9XuN38
0
1
10
@NeuroOnc
SNO
2 years
Dendritic cell vaccine trials in gliomas: Untangling the lines https://t.co/FLzt9XuN38
3
19
72
@KatyPetersMDPhD
Katy Peters
2 years
Thank you to the patients enrolled in INDIGO @Dukeneurosurg @Duke_Neurology @DukeCancer @AngelsAmongUsBT
@KatyPetersMDPhD
Katy Peters
2 years
INDIGO study results at #ASCO2023 plenary
0
1
8
@Cancers_MDPI
Cancers MDPI
2 years
📈Radiation necrosis is a growing challenge for brain metastasis patients in the era of combined modality therapy. This #review offers a critical appraisal of the literature and avenues for discovery✅ Find the full paper here👉 https://t.co/S8ykOJdhI6 👥by @EJVaios et al.
1
2
7
@EJVaios
Eugene Vaios, MD MBA
3 years
Thrilled to see this out! Great update on our understanding of radiation necrosis and avenues for discovery. Thanks to @SebastianWinter and our wonderful collaborators @DukeRadOnc @MGHCancerCenter @DukeCancer 👏🏻👏🏻👏🏻
@SebastianWinter
Sebastian F. Winter, MD PhD
3 years
Excellent work led by @EJVaios w/ colleagues @DukeCancer @MGHCancerCenter out in @Cancers_MDPI exploring new mechanisms and therapeutic avenues for #radiationnecrosis management in patients w/ brain metastases🧠 #immunotherapy #radonc #neuroonc Free PDF▶️
3
5
15
@DukeRadOnc
Duke Radiation Oncology
3 years
Congrats to @EJVaios, MD, MBA, who will represent Duke #RadOnc in the trainee poster session at the @DukeMedSchool Dean's Research Series. His poster explores long-term safety/toxicity outcomes following dual immune-checkpoint blockade in brain metastasis patients receiving SRS
@DukeMedSchool
Duke University School of Medicine
3 years
Mark your calendars for Thursday, March 30! The Dean’s Distinguished Research Series features: 📣 12-1 pm — Faculty Lectures by Cagla Eroglu, PhD, and Andrew West, PhD 📣 1-2:30 pm — Trainee Poster Session @c_eroglu @DukeCellBiology @Duke_PCB https://t.co/d9xFyuBp25
0
2
7
@KatyPetersMDPhD
Katy Peters
3 years
Finally Here. Dr. David Ashley kicks off #ICBTRT @Dukeneurosurg @DukeMets
@Dukeneurosurg
Duke Neurosurgery
3 years
After a 3-year (Covid) delay, we are excited to finally kick off the International Conference on Brain Tumor Research and Therapy, as North American host. Looking forward to seeing friends and colleagues soon on the island. #ICBTRT #AsilomarToKiawah
0
1
3
@KatyPetersMDPhD
Katy Peters
3 years
DC migration center stage with Dr. Kristen Batich @Dukeneurosurg @DukeCancer @AngelsAmongUsBT #ICBTRT
0
2
19
@PDBrownOnc
PDBrown
3 years
Does WBRT “age” the brain? Anatomic surface-based deep learning to estimate brain age w/MRI before & after WBRT WBRT aged brain 9x faster than controls WBRT hippos aged 9x faster than HA-WBRT SRS alone NOT diff compared to controls https://t.co/Oxj9chsxlb
Tweet card summary image
academic.oup.com
AbstractBackground. Brain metastases are the most common intracranial tumors in adults and are associated with significant morbidity and mortality. Whole-b
3
51
135
@NeuroOnc
SNO
3 years
Polio Virotherapy Targets the Malignant Glioma Myeloid Infiltrate with Diffuse Microglia Activation Engulfing the CNS https://t.co/pmKSImHyCk
0
3
12
@EJVaios
Eugene Vaios, MD MBA
3 years
Great updates from the @Dukeneurosurg brain tumor SPORE this morning at @NeurosurgUCSF. Neuro-onc fellow Kristen Batich MD PhD leading the way on CCL3 mediated DC migration and immune activation in GBM! 👏🏻 @dukegme @DukeCancer @DukeHealth
0
1
11
@DukeMets
Duke Center for Brain and Spine Metastasis
3 years
Thank you, Dr. Helen Shih! We loved having you as part of the invited prof lecture series. #radonc #CNSmetastases @Dukeneurosurg @DukeRadOnc @DukeCancer @MGHCancerCenter @DrVanSwearingen @CareyAnders1 @KatyPetersMDPhD @ScottFl58722881
1
3
32